Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Nuclear Medicine|October 6, 2009
Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CTGopinath Gnanasegaran, Gary Cook, Kathryn Adamson, et al.
The Journal of Dermatological Treatment|January 24, 2006
A randomized double-blind study to assess the effects of silicic acid compared to placebo in patients with mild to moderate acneCatherine Fernandez, Kathryn Adamson, Michael Dale, et al.
Seminars in Nuclear Medicine|October 6, 2009
Multislice SPECT/CT in benign and malignant bone disease: when the ordinary turns into the extraordinaryGopinath Gnanasegaran, Tara Barwick, Kathryn Adamson, et al.
The British Journal of Radiology|May 23, 2022
Guidance on medical physics expert support for nuclear medicineLouise Fraser, Nasreen Parkar, Kathryn Adamson, et al.
EJNMMI Research|May 31, 2023
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancerDaniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, et al.
Nuclear Medicine Communications|August 5, 2026
The practice of adult whole-body nuclear medicine bone scanning in the UK: opportunities to optimiseSamantha J Colosimo, Roger T Staff, Kathryn Adamson, et al.
Scientific Reports|September 10, 2016
Paradoxical cold conditions during the medieval climate anomaly in the Western ArcticVincent Jomelli, Timothy Lane, Vincent Favier, et al.
EJNMMI Research|May 17, 2023
[99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expressionMuhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, et al.
Nature Communications|September 21, 2022
60 million years of glaciation in the Transantarctic MountainsIestyn D Barr, Matteo Spagnolo, Brice R Rea, et al.
British Journal of Cancer|April 5, 2025
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancerDaniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, et al.
Pageof 2